Takeaway
Tau positron emission tomography (PET) binding is increased in symptomatic individuals with dominantly inherited Alzheimer’s disease (AD) and is associated with cognitive impairment and other disease biomarkers.
Why this matters ?
Tauopathy is a hallmark pathology of AD with a strong relationship with cognitive impairment; understanding tau could lead to promising clinical interventions.